Jacob A. Orville, General Manager, Screening at EXACT SCIENCES CORP (EXAS), sold 5,420 shares at $62.72 ($340K) on 2023-02-22, disclosed to the SEC on 2023-02-23.
Seasonal sale ($340k) by General Manager, Screening — this insider has traded EXAS in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.72 | 2,710 | $170K | 50.0% |
| 2 | $62.72 | 2,710 | $170K | 50.0% |
| Total | $62.72 avg | 5,420 | $340K | 100% |
| Filing → |
| EXAS | SELL | 2024-03-04 | $256K | — | Filing → |
| EXAS | SELL | 2024-02-28 | $214K | — | Filing → |
| EXAS | SELL | 2024-02-23 | $121K | — | Filing → |